 | • レポートコード：MRC2-11QY11288 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はキャッスルマン病治療のグローバル市場について調査・分析したレポートです。種類別（モノクローナル抗体、化学療法、放射線療法、免疫療法、コルチコステロイド、抗ウイルス薬）市場規模、用途別（病院、臨床、外来診療ユニット）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別キャッスルマン病治療の競争状況、市場シェア ・世界のキャッスルマン病治療市場：種類別市場規模 2015年-2020年（モノクローナル抗体、化学療法、放射線療法、免疫療法、コルチコステロイド、抗ウイルス薬） ・世界のキャッスルマン病治療市場：種類別市場規模予測 2021年-2026年（モノクローナル抗体、化学療法、放射線療法、免疫療法、コルチコステロイド、抗ウイルス薬） ・世界のキャッスルマン病治療市場：用途別市場規模 2015年-2020年（病院、臨床、外来診療ユニット） ・世界のキャッスルマン病治療市場：用途別市場規模予測 2021年-2026年（病院、臨床、外来診療ユニット） ・北米のキャッスルマン病治療市場分析：米国、カナダ ・ヨーロッパのキャッスルマン病治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのキャッスルマン病治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のキャッスルマン病治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのキャッスルマン病治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Johnson & Johnson、F.Hoffmann-La Roche、Bristol-Myers Squibb、Merck、Pfizer、Hospira、Incyte、Novartis ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Castleman disease is a rare condition of lymph nodes and similar tissues. This condition occurs when too many non-cancer cells started to grow in the lymph node. After initial growth hard growth started to form. Usually, it occurs in the chest, abdomen or neck. This condition is also called as angiofollicular lymph node hyperplasia. There are no known risk factors for castleman disease, but it usually occur in adults with weakened immune system.
The factor driving the growth of the castleman disease market is the life style. In today’s time, immune system of people is getting weaker due to various life style conditions. Increasing prevalence of AIDS is also driving the growth of castleman disease treatment market. Government support for the development of orphan drugs and allowing premium pricing of these drugs will be helpful in generating high revenue for companies. High unmet need also expected to drive the growth of castleman disease treatment market.
Market Analysis and Insights: Global Castleman Disease Treatment Market
The global Castleman Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Castleman Disease Treatment Scope and Market Size
Castleman Disease Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Castleman Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Johnson & Johnson
F.Hoffmann-La Roche
Bristol-Myers Squibb
Merck
Pfizer
Hospira
Incyte
Novartis
Market segment by Type, the product can be split into
Monoclonal Antibodies
Chemotherapy
Radiation Therapy
Immunotherapy
Corticosteroids
Antiviral Drugs
Market segment by Application, split into
Hospitals
Clinical
Ambulatory Care Units
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Castleman Disease Treatment Revenue
1.4 Market by Type
1.4.1 Global Castleman Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monoclonal Antibodies
1.4.3 Chemotherapy
1.4.4 Radiation Therapy
1.4.5 Immunotherapy
1.4.6 Corticosteroids
1.4.7 Antiviral Drugs
1.5 Market by Application
1.5.1 Global Castleman Disease Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinical
1.5.4 Ambulatory Care Units
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Castleman Disease Treatment Market Perspective (2015-2026)
2.2 Global Castleman Disease Treatment Growth Trends by Regions
2.2.1 Castleman Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Castleman Disease Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Castleman Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Castleman Disease Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Castleman Disease Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Castleman Disease Treatment Players by Market Size
3.1.1 Global Top Castleman Disease Treatment Players by Revenue (2015-2020)
3.1.2 Global Castleman Disease Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Castleman Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Castleman Disease Treatment Market Concentration Ratio
3.2.1 Global Castleman Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Castleman Disease Treatment Revenue in 2019
3.3 Castleman Disease Treatment Key Players Head office and Area Served
3.4 Key Players Castleman Disease Treatment Product Solution and Service
3.5 Date of Enter into Castleman Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Castleman Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Castleman Disease Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Castleman Disease Treatment Market Size by Application (2015-2020)
5.2 Global Castleman Disease Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Castleman Disease Treatment Market Size (2015-2020)
6.2 Castleman Disease Treatment Key Players in North America (2019-2020)
6.3 North America Castleman Disease Treatment Market Size by Type (2015-2020)
6.4 North America Castleman Disease Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Castleman Disease Treatment Market Size (2015-2020)
7.2 Castleman Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Castleman Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Castleman Disease Treatment Market Size by Application (2015-2020)
8 China
8.1 China Castleman Disease Treatment Market Size (2015-2020)
8.2 Castleman Disease Treatment Key Players in China (2019-2020)
8.3 China Castleman Disease Treatment Market Size by Type (2015-2020)
8.4 China Castleman Disease Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Castleman Disease Treatment Market Size (2015-2020)
9.2 Castleman Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Castleman Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Castleman Disease Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Castleman Disease Treatment Market Size (2015-2020)
10.2 Castleman Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Castleman Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Castleman Disease Treatment Market Size by Application (2015-2020)
11 India
11.1 India Castleman Disease Treatment Market Size (2015-2020)
11.2 Castleman Disease Treatment Key Players in India (2019-2020)
11.3 India Castleman Disease Treatment Market Size by Type (2015-2020)
11.4 India Castleman Disease Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Castleman Disease Treatment Market Size (2015-2020)
12.2 Castleman Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Castleman Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Castleman Disease Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Details
13.1.2 Johnson & Johnson Business Overview
13.1.3 Johnson & Johnson Castleman Disease Treatment Introduction
13.1.4 Johnson & Johnson Revenue in Castleman Disease Treatment Business (2015-2020))
13.1.5 Johnson & Johnson Recent Development
13.2 F.Hoffmann-La Roche
13.2.1 F.Hoffmann-La Roche Company Details
13.2.2 F.Hoffmann-La Roche Business Overview
13.2.3 F.Hoffmann-La Roche Castleman Disease Treatment Introduction
13.2.4 F.Hoffmann-La Roche Revenue in Castleman Disease Treatment Business (2015-2020)
13.2.5 F.Hoffmann-La Roche Recent Development
13.3 Bristol-Myers Squibb
13.3.1 Bristol-Myers Squibb Company Details
13.3.2 Bristol-Myers Squibb Business Overview
13.3.3 Bristol-Myers Squibb Castleman Disease Treatment Introduction
13.3.4 Bristol-Myers Squibb Revenue in Castleman Disease Treatment Business (2015-2020)
13.3.5 Bristol-Myers Squibb Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Castleman Disease Treatment Introduction
13.4.4 Merck Revenue in Castleman Disease Treatment Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Pfizer
13.5.1 Pfizer Company Details
13.5.2 Pfizer Business Overview
13.5.3 Pfizer Castleman Disease Treatment Introduction
13.5.4 Pfizer Revenue in Castleman Disease Treatment Business (2015-2020)
13.5.5 Pfizer Recent Development
13.6 Hospira
13.6.1 Hospira Company Details
13.6.2 Hospira Business Overview
13.6.3 Hospira Castleman Disease Treatment Introduction
13.6.4 Hospira Revenue in Castleman Disease Treatment Business (2015-2020)
13.6.5 Hospira Recent Development
13.7 Incyte
13.7.1 Incyte Company Details
13.7.2 Incyte Business Overview
13.7.3 Incyte Castleman Disease Treatment Introduction
13.7.4 Incyte Revenue in Castleman Disease Treatment Business (2015-2020)
13.7.5 Incyte Recent Development
13.8 Novartis
13.8.1 Novartis Company Details
13.8.2 Novartis Business Overview
13.8.3 Novartis Castleman Disease Treatment Introduction
13.8.4 Novartis Revenue in Castleman Disease Treatment Business (2015-2020)
13.8.5 Novartis Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Castleman Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Castleman Disease Treatment Revenue
Table 3. Ranking of Global Top Castleman Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Castleman Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monoclonal Antibodies
Table 6. Key Players of Chemotherapy
Table 7. Key Players of Radiation Therapy
Table 8. Key Players of Immunotherapy
Table 9. Key Players of Corticosteroids
Table 10. Key Players of Antiviral Drugs
Table 11. Global Castleman Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Castleman Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Castleman Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Castleman Disease Treatment Market Share by Regions (2015-2020)
Table 15. Global Castleman Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Castleman Disease Treatment Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Castleman Disease Treatment Market Growth Strategy
Table 21. Main Points Interviewed from Key Castleman Disease Treatment Players
Table 22. Global Castleman Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 23. Global Castleman Disease Treatment Market Share by Players (2015-2020)
Table 24. Global Top Castleman Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Castleman Disease Treatment as of 2019)
Table 25. Global Castleman Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Castleman Disease Treatment Product Solution and Service
Table 28. Date of Enter into Castleman Disease Treatment Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Castleman Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 31. Global Castleman Disease Treatment Market Size Share by Type (2015-2020)
Table 32. Global Castleman Disease Treatment Revenue Market Share by Type (2021-2026)
Table 33. Global Castleman Disease Treatment Market Size Share by Application (2015-2020)
Table 34. Global Castleman Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 35. Global Castleman Disease Treatment Market Size Share by Application (2021-2026)
Table 36. North America Key Players Castleman Disease Treatment Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Castleman Disease Treatment Market Share (2019-2020)
Table 38. North America Castleman Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 39. North America Castleman Disease Treatment Market Share by Type (2015-2020)
Table 40. North America Castleman Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 41. North America Castleman Disease Treatment Market Share by Application (2015-2020)
Table 42. Europe Key Players Castleman Disease Treatment Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Castleman Disease Treatment Market Share (2019-2020)
Table 44. Europe Castleman Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Castleman Disease Treatment Market Share by Type (2015-2020)
Table 46. Europe Castleman Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Castleman Disease Treatment Market Share by Application (2015-2020)
Table 48. China Key Players Castleman Disease Treatment Revenue (2019-2020) (Million US$)
Table 49. China Key Players Castleman Disease Treatment Market Share (2019-2020)
Table 50. China Castleman Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 51. China Castleman Disease Treatment Market Share by Type (2015-2020)
Table 52. China Castleman Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 53. China Castleman Disease Treatment Market Share by Application (2015-2020)
Table 54. Japan Key Players Castleman Disease Treatment Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Castleman Disease Treatment Market Share (2019-2020)
Table 56. Japan Castleman Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Castleman Disease Treatment Market Share by Type (2015-2020)
Table 58. Japan Castleman Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Castleman Disease Treatment Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Castleman Disease Treatment Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Castleman Disease Treatment Market Share (2019-2020)
Table 62. Southeast Asia Castleman Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Castleman Disease Treatment Market Share by Type (2015-2020)
Table 64. Southeast Asia Castleman Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Castleman Disease Treatment Market Share by Application (2015-2020)
Table 66. India Key Players Castleman Disease Treatment Revenue (2019-2020) (Million US$)
Table 67. India Key Players Castleman Disease Treatment Market Share (2019-2020)
Table 68. India Castleman Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 69. India Castleman Disease Treatment Market Share by Type (2015-2020)
Table 70. India Castleman Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 71. India Castleman Disease Treatment Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Castleman Disease Treatment Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Castleman Disease Treatment Market Share (2019-2020)
Table 74. Central & South America Castleman Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Castleman Disease Treatment Market Share by Type (2015-2020)
Table 76. Central & South America Castleman Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Castleman Disease Treatment Market Share by Application (2015-2020)
Table 78. Johnson & Johnson Company Details
Table 79. Johnson & Johnson Business Overview
Table 80. Johnson & Johnson Product
Table 81. Johnson & Johnson Revenue in Castleman Disease Treatment Business (2015-2020) (Million US$)
Table 82. Johnson & Johnson Recent Development
Table 83. F.Hoffmann-La Roche Company Details
Table 84. F.Hoffmann-La Roche Business Overview
Table 85. F.Hoffmann-La Roche Product
Table 86. F.Hoffmann-La Roche Revenue in Castleman Disease Treatment Business (2015-2020) (Million US$)
Table 87. F.Hoffmann-La Roche Recent Development
Table 88. Bristol-Myers Squibb Company Details
Table 89. Bristol-Myers Squibb Business Overview
Table 90. Bristol-Myers Squibb Product
Table 91. Bristol-Myers Squibb Revenue in Castleman Disease Treatment Business (2015-2020) (Million US$)
Table 92. Bristol-Myers Squibb Recent Development
Table 93. Merck Company Details
Table 94. Merck Business Overview
Table 95. Merck Product
Table 96. Merck Revenue in Castleman Disease Treatment Business (2015-2020) (Million US$)
Table 97. Merck Recent Development
Table 98. Pfizer Company Details
Table 99. Pfizer Business Overview
Table 100. Pfizer Product
Table 101. Pfizer Revenue in Castleman Disease Treatment Business (2015-2020) (Million US$)
Table 102. Pfizer Recent Development
Table 103. Hospira Company Details
Table 104. Hospira Business Overview
Table 105. Hospira Product
Table 106. Hospira Revenue in Castleman Disease Treatment Business (2015-2020) (Million US$)
Table 107. Hospira Recent Development
Table 108. Incyte Company Details
Table 109. Incyte Business Overview
Table 110. Incyte Product
Table 111. Incyte Revenue in Castleman Disease Treatment Business (2015-2020) (Million US$)
Table 112. Incyte Recent Development
Table 113. Novartis Business Overview
Table 114. Novartis Product
Table 115. Novartis Company Details
Table 116. Novartis Revenue in Castleman Disease Treatment Business (2015-2020) (Million US$)
Table 117. Novartis Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Castleman Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Monoclonal Antibodies Features
Figure 3. Chemotherapy Features
Figure 4. Radiation Therapy Features
Figure 5. Immunotherapy Features
Figure 6. Corticosteroids Features
Figure 7. Antiviral Drugs Features
Figure 8. Global Castleman Disease Treatment Market Share by Application: 2020 VS 2026
Figure 9. Hospitals Case Studies
Figure 10. Clinical Case Studies
Figure 11. Ambulatory Care Units Case Studies
Figure 12. Castleman Disease Treatment Report Years Considered
Figure 13. Global Castleman Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Castleman Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 15. Global Castleman Disease Treatment Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Castleman Disease Treatment Market Share by Players in 2019
Figure 18. Global Top Castleman Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Castleman Disease Treatment as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Castleman Disease Treatment Revenue in 2019
Figure 20. North America Castleman Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Castleman Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Castleman Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Castleman Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Castleman Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Castleman Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Castleman Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
感染症治療の世界市場（～2026年） Treatment for Infectious Diseases. Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients. Market Analysis and Insights: Global Infectious Disease Treatment M…- クラッベ病治療の世界市場（～2026年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…
- ニューカッスル病治療の世界市場（～2026年） Newcastle Disease is a highly contagious disease of avian species especially poultry caused by avian Paramyxovirus type 1 (APMV-1). The North America is dominating and contributed the leading shares to the global Newcastle Disease Treatment market in terms of revenue and expected to register a signi…
- 筋萎縮性側索硬化症（ルーゲーリック病）治療の世界市場（～2026年） Amyotrophic Lateral Sclerosis (ALS) is a neurological disease that affects nerve cells in the brain and spinal cords which controls the activity of voluntary muscles. It is also termed as Lou Gehrig’s disease. There are several causes behind ALS which includes gene mutation, disorganized immune resp…
- クッシング病治療の世界市場（～2026年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…